Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - NET INCOME
Net Income AKBA - Akebia Therapeutics, Inc.
-51.9 M
LAST VALUE
57.15%
2 YEAR CAGR
18.41%
5 YEAR CAGR
-14.71%
10 YEAR CAGR